Table of Contents
Journal of Cancer Research
Volume 2014, Article ID 840906, 14 pages
http://dx.doi.org/10.1155/2014/840906
Research Article

miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model

Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, 73 Tsarigradsko Shosse Boulevard, 1113 Sofia, Bulgaria

Received 29 June 2014; Revised 18 September 2014; Accepted 24 September 2014; Published 14 October 2014

Academic Editor: Vincent J. Gnanapragasam

Copyright © 2014 Krassimira Todorova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Wright, M.-J. Tsai, and R. Aebersold, “Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells,” Molecular Endocrinology, vol. 17, no. 9, pp. 1726–1737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Huang, P. J. Hurley, B. W. Simons et al., “Sox9 is required for prostate development and prostate cancer initiation,” Oncotarget, vol. 3, no. 6, pp. 651–663, 2012. View at Google Scholar · View at Scopus
  3. S. A. Tomlins, B. Laxman, S. Varambally et al., “Role of the TMPRSS2-ERG gene fusion in prostate cancer,” Neoplasia, vol. 10, no. 2, pp. 177–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Yu, D. R. Rhodes, S. A. Tomlins et al., “A polycomb repression signature in metastatic prostate cancer predicts cancer outcome,” Cancer Research, vol. 67, no. 22, pp. 10657–10663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Davalos, C. Moutinho, A. Villanueva et al., “Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis,” Oncogene, vol. 31, no. 16, pp. 2062–2074, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Shen and C. Abate-Shen, “Molecular genetics of prostate cancer: New prospects for old challenges,” Genes and Development, vol. 24, no. 18, pp. 1967–2000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Heinlein and C. Chang, “Androgen receptor in prostate cancer,” Endocrine Reviews, vol. 25, no. 2, pp. 276–308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. E. Massie, B. Adryan, N. L. Barbosa-Morais et al., “New androgen receptor genomic targets show an interaction with the ETS1 transcription factor,” EMBO Reports, vol. 8, no. 9, pp. 871–878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Shiozawa, E. A. Pedersen, A. M. Havens et al., “Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow,” Journal of Clinical Investigation, vol. 121, no. 4, pp. 1298–1312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. C. Nicolaides, R. Gualdi, C. Casadevall, L. Manzella, and B. Calabretta, “Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene,” Molecular and Cellular Biology, vol. 11, no. 12, pp. 6166–6176, 1991. View at Google Scholar · View at Scopus
  11. F. Kalkbrenner, S. Guehmann, and K. Moelling, “Transcriptional activation by human c-myb and v-myb genes,” Oncogene, vol. 5, no. 5, pp. 657–661, 1990. View at Google Scholar · View at Scopus
  12. M. Lagos-Quintana, R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl, “Identification of tissue-specific MicroRNAs from mouse,” Current Biology, vol. 12, no. 9, pp. 735–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Lin, Q. Cao, J. Zhang et al., “MicroRNA expression patterns in indeterminate inflammatory bowel disease,” Modern Pathology, vol. 26, no. 1, pp. 148–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Narayanan, J. Jiang, Y. Gusev et al., “Micrornas are mediators of androgen action in prostate and muscle,” PLoS ONE, vol. 5, no. 10, Article ID e13637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Karaivanov, K. Todorova, A. Kuzmanov, and S. Hayrabedyan, “Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy,” Journal of Molecular Histology, vol. 38, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Todorova, S. Zoubak, M. Mincheff, and S. Kyurkchiev, “Biochemical nature and mapping of PSMA epitopes recognized by human antibodies induced after immunization with gene-based vaccines,” Anticancer Research, vol. 25, no. 6, pp. 4727–4732, 2005. View at Google Scholar · View at Scopus
  17. K. Todorova, I. Ignatova, S. Tchakarov et al., “Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded,” Cancer Immunity, vol. 5, article 1, 2005. View at Google Scholar · View at Scopus
  18. K. Todorova, M. Mincheff, S. Hayrabedyan et al., “Fundamental role of microRNAs in androgen-dependent male reproductive biology and prostate cancerogenesis,” American Journal of Reproductive Immunology, vol. 69, no. 2, pp. 100–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Korpal, E. S. Lee, G. Hu, and Y. Kang, “The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2,” The Journal of Biological Chemistry, vol. 283, no. 22, pp. 14910–14914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Huang, L. Zhao, L. Xing, and D. Chen, “MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation,” Stem Cells, vol. 28, no. 2, pp. 357–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Gibas, R. Becher, E. Kawinski, J. Horoszewicz, and A. A. Sandberg, “A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP),” Cancer Genetics and Cytogenetics, vol. 11, no. 4, pp. 399–404, 1984. View at Publisher · View at Google Scholar · View at Scopus
  22. M. E. Kaighn, K. S. Narayan, Y. Ohnuki, J. F. Lechner, and L. W. Jones, “Establishment and characterization of a human prostatic carcinoma cell line (PC-3),” Investigative Urology, vol. 17, no. 1, pp. 16–23, 1979. View at Google Scholar · View at Scopus
  23. S. Korenchuk, J. E. Lehr, L. McLean et al., “VCaP, a cell-based model system of human prostate cancer,” In Vivo, vol. 15, no. 2, pp. 163–168, 2001. View at Google Scholar · View at Scopus
  24. S.-L. Lai, H. Brauch, T. Knutsen et al., “Molecular genetic characterization of neuroendocrine lung cancer cell lines,” Anticancer Research, vol. 15, no. 2, pp. 225–232, 1995. View at Google Scholar · View at Scopus
  25. M. Ishiyama, H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno, “A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet,” Biological and Pharmaceutical Bulletin, vol. 19, no. 11, pp. 1518–1520, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Markus, R. B. Gerstner, D. E. Draper, and D. A. Torchia, “Refining the overall structure and subdomain orientation of ribosomal protein S4 Δ41 with dipolar couplings measured by NMR in uniaxial liquid crystalline phases,” Journal of Molecular Biology, vol. 292, no. 2, pp. 375–387, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. P. O. Krutzik and G. P. Nolan, “Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events,” Cytometry A, vol. 55, no. 2, pp. 61–70, 2003. View at Google Scholar · View at Scopus
  28. J. M. Irish, R. Hovland, P. O. Krutzik et al., “Single cell profiling of potentiated phospho-protein networks in cancer cells,” Cell, vol. 118, no. 2, pp. 217–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Sun, S. Koo, N. White et al., “Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs,” Nucleic Acids Research, vol. 32, no. 22, p. e188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. P. Turner, V. J. Findlay, O. Moussa et al., “Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression,” Prostate, vol. 71, no. 16, pp. 1723–1735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Imam, J. R. Plyler, H. Bansal et al., “Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization,” PLoS ONE, vol. 7, no. 12, Article ID e52397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Lee, X. Yang, Y. Huang et al., “Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis,” PLoS Computational Biology, vol. 6, no. 4, Article ID e1000730, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Sharma and A. Lichtenstein, “Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells,” Blood, vol. 114, no. 19, pp. 4179–4185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. I. M. Shapiro, A. W. Cheng, N. C. Flytzanis et al., “An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype,” PLoS Genetics, vol. 7, no. 8, Article ID e1002218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Cai, H. Wang, H. H. He et al., “ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer,” Journal of Clinical Investigation, vol. 123, no. 3, pp. 1109–1122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-F. Yuen, W.-K. Kwok, K.-K. Chan et al., “TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction,” Carcinogenesis, vol. 29, no. 8, pp. 1509–1518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Gavard, V. Patel, and J. S. Gutkind, “Gutkind, Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia,” Developmental Cell, vol. 14, no. 1, pp. 25–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Courboulin, R. Paulin, N. J. Giguère et al., “Role for miR-204 in human pulmonary arterial hypertension,” Journal of Experimental Medicine, vol. 208, no. 3, pp. 535–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Lambertini, G. Lisignoli, E. Torreggiani et al., “Slug gene expression supports human osteoblast maturation,” Cellular and Molecular Life Sciences, vol. 66, no. 22, pp. 3641–3653, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Akech, J. J. Wixted, K. Bedard et al., “Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions,” Oncogene, vol. 29, no. 6, pp. 811–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. K. Baniwal, O. Khalid, Y. Gabet et al., “Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis,” Molecular Cancer, vol. 9, article 258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Lambertini, T. Franceschetti, E. Torreggiani et al., “SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts,” BMC Molecular Biology, vol. 11, article 13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. G. H. Little, S. K. Baniwal, H. Adisetiyo et al., “Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness,” Cancer Research, vol. 74, no. 10, pp. 2857–2868, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Shirakihara, M. Saitoh, and K. Miyazono, “Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial-mesenchymal transition induced by TGF-β,” Molecular Biology of the Cell, vol. 18, no. 9, pp. 3533–3544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Cheng and P. G. Genever, “SOX9 determines RUNX2 transactivity by directing intracellular degradation,” Journal of Bone and Mineral Research, vol. 25, no. 12, pp. 2680–2689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Gao, G. H. Kim, A. C. Mackinnon et al., “Ets1 is required for proper migration and differentiation of the cardiac neural crest,” Development, vol. 137, no. 9, pp. 1543–1551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Matalová, M. Buchtová, A. S. Tucker et al., “Expression and characterization of c-Myb in prenatal odontogenesis,” Development Growth and Differentiation, vol. 53, no. 6, pp. 793–803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Oralova, M. Buchtova, E. Janeckova, A. Tucker, and E. Matalova, “Modulation of c-Myb during chondrogenesis,” Bone Abstracts, vol. 1, Article ID PP252, 2013. View at Publisher · View at Google Scholar